nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Nadolol—hypertension	0.28	1	CrCtD
Salbutamol—ADRB1—hypertension	0.0753	0.543	CbGaD
Salbutamol—ADRB2—hypertension	0.0633	0.457	CbGaD
Salbutamol—Pirbuterol—Nadolol—hypertension	0.018	0.0783	CrCrCtD
Salbutamol—ADRB2—Esmolol—hypertension	0.0151	0.0619	CbGbCtD
Salbutamol—ADRB1—Esmolol—hypertension	0.0148	0.061	CbGbCtD
Salbutamol—Carteolol—Nadolol—hypertension	0.0143	0.0622	CrCrCtD
Salbutamol—Levobunolol—Nadolol—hypertension	0.0143	0.0622	CrCrCtD
Salbutamol—Salmeterol—Labetalol—hypertension	0.0136	0.0594	CrCrCtD
Salbutamol—Levobunolol—Timolol—hypertension	0.0121	0.0529	CrCrCtD
Salbutamol—ADRB2—Nadolol—hypertension	0.0114	0.0469	CbGbCtD
Salbutamol—ADRB2—Nebivolol—hypertension	0.0114	0.0469	CbGbCtD
Salbutamol—ADRB2—Labetalol—hypertension	0.0114	0.0469	CbGbCtD
Salbutamol—ADRB1—Labetalol—hypertension	0.0113	0.0462	CbGbCtD
Salbutamol—ADRB1—Nadolol—hypertension	0.0113	0.0462	CbGbCtD
Salbutamol—ADRB1—Nebivolol—hypertension	0.0113	0.0462	CbGbCtD
Salbutamol—Nadolol—Pindolol—hypertension	0.0106	0.046	CrCrCtD
Salbutamol—Carteolol—Pindolol—hypertension	0.0106	0.046	CrCrCtD
Salbutamol—Levobunolol—Pindolol—hypertension	0.0106	0.046	CrCrCtD
Salbutamol—ADRB2—Acebutolol—hypertension	0.0104	0.0429	CbGbCtD
Salbutamol—Bupranolol—Nadolol—hypertension	0.0103	0.045	CrCrCtD
Salbutamol—Carteolol—Penbutolol—hypertension	0.0103	0.045	CrCrCtD
Salbutamol—Nadolol—Penbutolol—hypertension	0.0103	0.045	CrCrCtD
Salbutamol—Levobunolol—Penbutolol—hypertension	0.0103	0.045	CrCrCtD
Salbutamol—ADRB1—Acebutolol—hypertension	0.0103	0.0422	CbGbCtD
Salbutamol—ADRB2—Metoprolol—hypertension	0.00971	0.0399	CbGbCtD
Salbutamol—ADRB2—Pindolol—hypertension	0.00971	0.0399	CbGbCtD
Salbutamol—ADRB1—Pindolol—hypertension	0.00957	0.0393	CbGbCtD
Salbutamol—ADRB1—Metoprolol—hypertension	0.00957	0.0393	CbGbCtD
Salbutamol—Isoetarine—Methyldopa—hypertension	0.00942	0.041	CrCrCtD
Salbutamol—Norepinephrine—Methyldopa—hypertension	0.00878	0.0383	CrCrCtD
Salbutamol—Bupranolol—Timolol—hypertension	0.00878	0.0383	CrCrCtD
Salbutamol—ADRB2—Betaxolol—hypertension	0.00866	0.0355	CbGbCtD
Salbutamol—ADRB1—Betaxolol—hypertension	0.00853	0.035	CbGbCtD
Salbutamol—Levonordefrin—Methyldopa—hypertension	0.00824	0.0359	CrCrCtD
Salbutamol—ADRB2—Penbutolol—hypertension	0.00792	0.0325	CbGbCtD
Salbutamol—ADRB1—Penbutolol—hypertension	0.0078	0.032	CbGbCtD
Salbutamol—Bupranolol—Pindolol—hypertension	0.00764	0.0333	CrCrCtD
Salbutamol—Bupranolol—Penbutolol—hypertension	0.00747	0.0325	CrCrCtD
Salbutamol—Epinephrine—Methyldopa—hypertension	0.00665	0.029	CrCrCtD
Salbutamol—Levobunolol—Propranolol—hypertension	0.00647	0.0282	CrCrCtD
Salbutamol—Carteolol—Propranolol—hypertension	0.00647	0.0282	CrCrCtD
Salbutamol—ADRB2—Timolol—hypertension	0.00558	0.0229	CbGbCtD
Salbutamol—ADRB1—Timolol—hypertension	0.0055	0.0226	CbGbCtD
Salbutamol—Isoprenaline—Methyldopa—hypertension	0.00541	0.0236	CrCrCtD
Salbutamol—ADRB2—Carvedilol—hypertension	0.0054	0.0222	CbGbCtD
Salbutamol—ADRB1—Carvedilol—hypertension	0.00532	0.0218	CbGbCtD
Salbutamol—ADRB2—Propranolol—hypertension	0.00497	0.0204	CbGbCtD
Salbutamol—ADRB1—Propranolol—hypertension	0.0049	0.0201	CbGbCtD
Salbutamol—Isoprenaline—Pindolol—hypertension	0.0047	0.0205	CrCrCtD
Salbutamol—Isoprenaline—Labetalol—hypertension	0.00417	0.0182	CrCrCtD
Salbutamol—CYP3A4—Guanethidine—hypertension	0.0024	0.00987	CbGbCtD
Salbutamol—CYP3A4—Hydralazine—hypertension	0.00182	0.00748	CbGbCtD
Salbutamol—CYP3A4—Guanfacine—hypertension	0.00155	0.00636	CbGbCtD
Salbutamol—CYP3A4—Isradipine—hypertension	0.00138	0.00567	CbGbCtD
Salbutamol—CYP3A4—Indapamide—hypertension	0.00122	0.00499	CbGbCtD
Salbutamol—CYP3A4—Nisoldipine—hypertension	0.00122	0.00499	CbGbCtD
Salbutamol—CYP3A4—Eplerenone—hypertension	0.00117	0.00482	CbGbCtD
Salbutamol—CYP3A4—Diltiazem—hypertension	0.00117	0.00482	CbGbCtD
Salbutamol—CYP3A4—Enalapril—hypertension	0.00105	0.0043	CbGbCtD
Salbutamol—CYP3A4—Irbesartan—hypertension	0.000957	0.00393	CbGbCtD
Salbutamol—CYP3A4—Amlodipine—hypertension	0.000939	0.00385	CbGbCtD
Salbutamol—CYP3A4—Felodipine—hypertension	0.000905	0.00372	CbGbCtD
Salbutamol—CYP3A4—Nifedipine—hypertension	0.000875	0.00359	CbGbCtD
Salbutamol—CYP3A4—Nicardipine—hypertension	0.000862	0.00354	CbGbCtD
Salbutamol—CYP3A4—Carvedilol—hypertension	0.000862	0.00354	CbGbCtD
Salbutamol—CYP3A4—Propranolol—hypertension	0.000793	0.00326	CbGbCtD
Salbutamol—CYP3A4—Clonidine—hypertension	0.000757	0.00311	CbGbCtD
Salbutamol—CYP3A4—Atorvastatin—hypertension	0.000674	0.00277	CbGbCtD
Salbutamol—CYP3A4—Losartan—hypertension	0.000617	0.00253	CbGbCtD
Salbutamol—ADRB2—Treprostinil—Nadolol—hypertension	0.00055	1	CbGdCrCtD
Salbutamol—CYP3A4—Verapamil—hypertension	0.000544	0.00223	CbGbCtD
Salbutamol—Clenbuterol—NGF—hypertension	0.000207	0.103	CrCbGaD
Salbutamol—Isoprenaline—PIK3R1—hypertension	0.000129	0.0647	CrCbGaD
Salbutamol—Isoprenaline—ADRBK1—hypertension	9.35e-05	0.0468	CrCbGaD
Salbutamol—Epinephrine—ADRBK1—hypertension	7.85e-05	0.0393	CrCbGaD
Salbutamol—Levonordefrin—ADRA2B—hypertension	7.54e-05	0.0377	CrCbGaD
Salbutamol—Levonordefrin—SLC6A2—hypertension	6.62e-05	0.0331	CrCbGaD
Salbutamol—Pirbuterol—ADRB1—hypertension	6.48e-05	0.0324	CrCbGaD
Salbutamol—Levobunolol—ADRB1—hypertension	5.78e-05	0.0289	CrCbGaD
Salbutamol—Pirbuterol—ADRB2—hypertension	5.45e-05	0.0273	CrCbGaD
Salbutamol—Phenylephrine—ADRA1A—hypertension	5.4e-05	0.027	CrCbGaD
Salbutamol—Isoetarine—ADRB1—hypertension	5.09e-05	0.0255	CrCbGaD
Salbutamol—Carteolol—ADRB1—hypertension	4.91e-05	0.0246	CrCbGaD
Salbutamol—Levobunolol—ADRB2—hypertension	4.86e-05	0.0243	CrCbGaD
Salbutamol—Salmeterol—CYP3A5—hypertension	4.78e-05	0.0239	CrCbGaD
Salbutamol—Levonordefrin—ADRA1A—hypertension	4.66e-05	0.0233	CrCbGaD
Salbutamol—Norepinephrine—ADRA2B—hypertension	4.47e-05	0.0224	CrCbGaD
Salbutamol—Terbutaline—ADRB2—hypertension	4.44e-05	0.0222	CrCbGaD
Salbutamol—Nadolol—ADRB1—hypertension	4.38e-05	0.0219	CrCbGaD
Salbutamol—Isoetarine—ADRB2—hypertension	4.28e-05	0.0214	CrCbGaD
Salbutamol—Clenbuterol—ADRB1—hypertension	4.22e-05	0.0211	CrCbGaD
Salbutamol—Bupranolol—ADRB1—hypertension	4.18e-05	0.0209	CrCbGaD
Salbutamol—Carteolol—ADRB2—hypertension	4.13e-05	0.0207	CrCbGaD
Salbutamol—Epinephrine—ADRA2B—hypertension	4.06e-05	0.0203	CrCbGaD
Salbutamol—Clenbuterol—TNF—hypertension	4.01e-05	0.0201	CrCbGaD
Salbutamol—Norepinephrine—SLC6A2—hypertension	3.93e-05	0.0196	CrCbGaD
Salbutamol—Salmeterol—ADRB2—hypertension	3.78e-05	0.0189	CrCbGaD
Salbutamol—Nadolol—ADRB2—hypertension	3.68e-05	0.0184	CrCbGaD
Salbutamol—Clenbuterol—ADRB2—hypertension	3.55e-05	0.0178	CrCbGaD
Salbutamol—Bupranolol—ADRB2—hypertension	3.51e-05	0.0176	CrCbGaD
Salbutamol—Levonordefrin—ADRA2A—hypertension	3.3e-05	0.0165	CrCbGaD
Salbutamol—Clenbuterol—CYP1A1—hypertension	3.05e-05	0.0152	CrCbGaD
Salbutamol—Norepinephrine—ADRA1A—hypertension	2.77e-05	0.0138	CrCbGaD
Salbutamol—Epinephrine—ADRA1A—hypertension	2.51e-05	0.0126	CrCbGaD
Salbutamol—Isoprenaline—ADRB1—hypertension	2.11e-05	0.0106	CrCbGaD
Salbutamol—Norepinephrine—ADRA2A—hypertension	1.96e-05	0.0098	CrCbGaD
Salbutamol—Norepinephrine—ADRB1—hypertension	1.96e-05	0.00979	CrCbGaD
Salbutamol—Epinephrine—ADRA2A—hypertension	1.78e-05	0.00889	CrCbGaD
Salbutamol—Isoprenaline—ADRB2—hypertension	1.78e-05	0.00889	CrCbGaD
Salbutamol—Epinephrine—ADRB1—hypertension	1.77e-05	0.00888	CrCbGaD
Salbutamol—Epinephrine—TNF—hypertension	1.68e-05	0.00843	CrCbGaD
Salbutamol—Norepinephrine—ADRB2—hypertension	1.64e-05	0.00823	CrCbGaD
Salbutamol—Isoprenaline—CYP1A1—hypertension	1.52e-05	0.00762	CrCbGaD
Salbutamol—Epinephrine—ADRB2—hypertension	1.49e-05	0.00747	CrCbGaD
Salbutamol—Norepinephrine—DRD2—hypertension	1.49e-05	0.00744	CrCbGaD
Salbutamol—Body temperature increased—Irbesartan—hypertension	7.56e-06	9.67e-05	CcSEcCtD
Salbutamol—Abdominal pain—Irbesartan—hypertension	7.56e-06	9.67e-05	CcSEcCtD
Salbutamol—Oedema—Timolol—hypertension	7.54e-06	9.65e-05	CcSEcCtD
Salbutamol—Anaphylactic shock—Timolol—hypertension	7.54e-06	9.65e-05	CcSEcCtD
Salbutamol—Loss of consciousness—Lisinopril—hypertension	7.53e-06	9.64e-05	CcSEcCtD
Salbutamol—Rash—Verapamil—hypertension	7.53e-06	9.64e-05	CcSEcCtD
Salbutamol—Urticaria—Hydrochlorothiazide—hypertension	7.53e-06	9.64e-05	CcSEcCtD
Salbutamol—Tachycardia—Ramipril—hypertension	7.53e-06	9.63e-05	CcSEcCtD
Salbutamol—Dermatitis—Verapamil—hypertension	7.53e-06	9.63e-05	CcSEcCtD
Salbutamol—Headache—Nifedipine—hypertension	7.52e-06	9.62e-05	CcSEcCtD
Salbutamol—Pruritus—Clonidine—hypertension	7.5e-06	9.6e-05	CcSEcCtD
Salbutamol—Abdominal pain—Hydrochlorothiazide—hypertension	7.49e-06	9.59e-05	CcSEcCtD
Salbutamol—Body temperature increased—Hydrochlorothiazide—hypertension	7.49e-06	9.59e-05	CcSEcCtD
Salbutamol—Skin disorder—Ramipril—hypertension	7.49e-06	9.59e-05	CcSEcCtD
Salbutamol—Infection—Timolol—hypertension	7.49e-06	9.59e-05	CcSEcCtD
Salbutamol—Headache—Verapamil—hypertension	7.48e-06	9.58e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Telmisartan—hypertension	7.48e-06	9.58e-05	CcSEcCtD
Salbutamol—Cough—Lisinopril—hypertension	7.48e-06	9.57e-05	CcSEcCtD
Salbutamol—Nausea—Diltiazem—hypertension	7.47e-06	9.55e-05	CcSEcCtD
Salbutamol—Nausea—Indapamide—hypertension	7.47e-06	9.55e-05	CcSEcCtD
Salbutamol—Hyperhidrosis—Ramipril—hypertension	7.46e-06	9.54e-05	CcSEcCtD
Salbutamol—Asthenia—Trandolapril—hypertension	7.42e-06	9.49e-05	CcSEcCtD
Salbutamol—Shock—Timolol—hypertension	7.42e-06	9.49e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Losartan—hypertension	7.41e-06	9.49e-05	CcSEcCtD
Salbutamol—Urticaria—Furosemide—hypertension	7.41e-06	9.48e-05	CcSEcCtD
Salbutamol—Nervous system disorder—Timolol—hypertension	7.39e-06	9.46e-05	CcSEcCtD
Salbutamol—Nausea—Carvedilol—hypertension	7.39e-06	9.46e-05	CcSEcCtD
Salbutamol—Asthenia—Enalapril—hypertension	7.39e-06	9.45e-05	CcSEcCtD
Salbutamol—Abdominal pain—Furosemide—hypertension	7.37e-06	9.43e-05	CcSEcCtD
Salbutamol—Body temperature increased—Furosemide—hypertension	7.37e-06	9.43e-05	CcSEcCtD
Salbutamol—Gastrointestinal pain—Losartan—hypertension	7.36e-06	9.41e-05	CcSEcCtD
Salbutamol—Dizziness—Valsartan—hypertension	7.35e-06	9.41e-05	CcSEcCtD
Salbutamol—Anorexia—Ramipril—hypertension	7.35e-06	9.41e-05	CcSEcCtD
Salbutamol—Urticaria—Betaxolol—hypertension	7.33e-06	9.38e-05	CcSEcCtD
Salbutamol—Skin disorder—Timolol—hypertension	7.32e-06	9.37e-05	CcSEcCtD
Salbutamol—Dizziness—Olmesartan—hypertension	7.32e-06	9.37e-05	CcSEcCtD
Salbutamol—Pruritus—Trandolapril—hypertension	7.32e-06	9.36e-05	CcSEcCtD
Salbutamol—Nausea—Doxazosin—hypertension	7.31e-06	9.36e-05	CcSEcCtD
Salbutamol—Arthralgia—Lisinopril—hypertension	7.3e-06	9.34e-05	CcSEcCtD
Salbutamol—Chest pain—Lisinopril—hypertension	7.3e-06	9.34e-05	CcSEcCtD
Salbutamol—Myalgia—Lisinopril—hypertension	7.3e-06	9.34e-05	CcSEcCtD
Salbutamol—Body temperature increased—Betaxolol—hypertension	7.3e-06	9.34e-05	CcSEcCtD
Salbutamol—Hyperhidrosis—Timolol—hypertension	7.29e-06	9.33e-05	CcSEcCtD
Salbutamol—Asthenia—Telmisartan—hypertension	7.29e-06	9.33e-05	CcSEcCtD
Salbutamol—Pruritus—Enalapril—hypertension	7.29e-06	9.32e-05	CcSEcCtD
Salbutamol—Anxiety—Lisinopril—hypertension	7.27e-06	9.3e-05	CcSEcCtD
Salbutamol—Diarrhoea—Clonidine—hypertension	7.25e-06	9.28e-05	CcSEcCtD
Salbutamol—Nausea—Fosinopril—hypertension	7.22e-06	9.24e-05	CcSEcCtD
Salbutamol—Discomfort—Lisinopril—hypertension	7.21e-06	9.23e-05	CcSEcCtD
Salbutamol—Hypotension—Ramipril—hypertension	7.21e-06	9.22e-05	CcSEcCtD
Salbutamol—Anorexia—Timolol—hypertension	7.19e-06	9.2e-05	CcSEcCtD
Salbutamol—Pruritus—Telmisartan—hypertension	7.19e-06	9.2e-05	CcSEcCtD
Salbutamol—Nausea—Eplerenone—hypertension	7.18e-06	9.19e-05	CcSEcCtD
Salbutamol—Urticaria—Losartan—hypertension	7.15e-06	9.14e-05	CcSEcCtD
Salbutamol—Dry mouth—Lisinopril—hypertension	7.14e-06	9.13e-05	CcSEcCtD
Salbutamol—Nausea—Nifedipine—hypertension	7.13e-06	9.12e-05	CcSEcCtD
Salbutamol—Body temperature increased—Losartan—hypertension	7.11e-06	9.1e-05	CcSEcCtD
Salbutamol—Abdominal pain—Losartan—hypertension	7.11e-06	9.1e-05	CcSEcCtD
Salbutamol—Nausea—Verapamil—hypertension	7.1e-06	9.08e-05	CcSEcCtD
Salbutamol—Asthenia—Captopril—hypertension	7.09e-06	9.07e-05	CcSEcCtD
Salbutamol—Diarrhoea—Trandolapril—hypertension	7.07e-06	9.05e-05	CcSEcCtD
Salbutamol—Vomiting—Valsartan—hypertension	7.07e-06	9.05e-05	CcSEcCtD
Salbutamol—Diarrhoea—Enalapril—hypertension	7.05e-06	9.02e-05	CcSEcCtD
Salbutamol—Hypotension—Timolol—hypertension	7.05e-06	9.02e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Irbesartan—hypertension	7.04e-06	9.01e-05	CcSEcCtD
Salbutamol—Vomiting—Olmesartan—hypertension	7.04e-06	9.01e-05	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Ramipril—hypertension	7.03e-06	8.99e-05	CcSEcCtD
Salbutamol—Rash—Valsartan—hypertension	7.01e-06	8.97e-05	CcSEcCtD
Salbutamol—Dizziness—Clonidine—hypertension	7.01e-06	8.97e-05	CcSEcCtD
Salbutamol—Dermatitis—Valsartan—hypertension	7.01e-06	8.97e-05	CcSEcCtD
Salbutamol—Oedema—Lisinopril—hypertension	6.99e-06	8.95e-05	CcSEcCtD
Salbutamol—Anaphylactic shock—Lisinopril—hypertension	6.99e-06	8.95e-05	CcSEcCtD
Salbutamol—Pruritus—Captopril—hypertension	6.99e-06	8.94e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Hydrochlorothiazide—hypertension	6.98e-06	8.94e-05	CcSEcCtD
Salbutamol—Rash—Olmesartan—hypertension	6.98e-06	8.93e-05	CcSEcCtD
Salbutamol—Insomnia—Ramipril—hypertension	6.98e-06	8.93e-05	CcSEcCtD
Salbutamol—Dermatitis—Olmesartan—hypertension	6.97e-06	8.92e-05	CcSEcCtD
Salbutamol—Headache—Valsartan—hypertension	6.97e-06	8.92e-05	CcSEcCtD
Salbutamol—Diarrhoea—Telmisartan—hypertension	6.95e-06	8.89e-05	CcSEcCtD
Salbutamol—Infection—Lisinopril—hypertension	6.95e-06	8.89e-05	CcSEcCtD
Salbutamol—Headache—Olmesartan—hypertension	6.93e-06	8.87e-05	CcSEcCtD
Salbutamol—Paraesthesia—Ramipril—hypertension	6.93e-06	8.86e-05	CcSEcCtD
Salbutamol—Shock—Lisinopril—hypertension	6.88e-06	8.81e-05	CcSEcCtD
Salbutamol—Asthenia—Perindopril—hypertension	6.88e-06	8.8e-05	CcSEcCtD
Salbutamol—Dyspnoea—Ramipril—hypertension	6.88e-06	8.8e-05	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Timolol—hypertension	6.87e-06	8.79e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Furosemide—hypertension	6.87e-06	8.79e-05	CcSEcCtD
Salbutamol—Asthenia—Irbesartan—hypertension	6.86e-06	8.78e-05	CcSEcCtD
Salbutamol—Somnolence—Ramipril—hypertension	6.86e-06	8.77e-05	CcSEcCtD
Salbutamol—Dizziness—Trandolapril—hypertension	6.84e-06	8.75e-05	CcSEcCtD
Salbutamol—Tachycardia—Lisinopril—hypertension	6.83e-06	8.74e-05	CcSEcCtD
Salbutamol—Insomnia—Timolol—hypertension	6.82e-06	8.73e-05	CcSEcCtD
Salbutamol—Dizziness—Enalapril—hypertension	6.81e-06	8.71e-05	CcSEcCtD
Salbutamol—Asthenia—Hydrochlorothiazide—hypertension	6.8e-06	8.7e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Betaxolol—hypertension	6.8e-06	8.7e-05	CcSEcCtD
Salbutamol—Skin disorder—Lisinopril—hypertension	6.79e-06	8.69e-05	CcSEcCtD
Salbutamol—Dyspepsia—Ramipril—hypertension	6.79e-06	8.69e-05	CcSEcCtD
Salbutamol—Pruritus—Perindopril—hypertension	6.78e-06	8.68e-05	CcSEcCtD
Salbutamol—Paraesthesia—Timolol—hypertension	6.77e-06	8.66e-05	CcSEcCtD
Salbutamol—Pruritus—Irbesartan—hypertension	6.76e-06	8.65e-05	CcSEcCtD
Salbutamol—Hyperhidrosis—Lisinopril—hypertension	6.76e-06	8.65e-05	CcSEcCtD
Salbutamol—Diarrhoea—Captopril—hypertension	6.76e-06	8.65e-05	CcSEcCtD
Salbutamol—Vomiting—Clonidine—hypertension	6.74e-06	8.63e-05	CcSEcCtD
Salbutamol—Dyspnoea—Timolol—hypertension	6.72e-06	8.6e-05	CcSEcCtD
Salbutamol—Dizziness—Telmisartan—hypertension	6.72e-06	8.6e-05	CcSEcCtD
Salbutamol—Pruritus—Hydrochlorothiazide—hypertension	6.71e-06	8.58e-05	CcSEcCtD
Salbutamol—Decreased appetite—Ramipril—hypertension	6.7e-06	8.58e-05	CcSEcCtD
Salbutamol—Somnolence—Timolol—hypertension	6.7e-06	8.58e-05	CcSEcCtD
Salbutamol—Asthenia—Furosemide—hypertension	6.69e-06	8.56e-05	CcSEcCtD
Salbutamol—Rash—Clonidine—hypertension	6.68e-06	8.55e-05	CcSEcCtD
Salbutamol—Dermatitis—Clonidine—hypertension	6.68e-06	8.55e-05	CcSEcCtD
Salbutamol—Anorexia—Lisinopril—hypertension	6.67e-06	8.53e-05	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Ramipril—hypertension	6.66e-06	8.52e-05	CcSEcCtD
Salbutamol—Fatigue—Ramipril—hypertension	6.65e-06	8.51e-05	CcSEcCtD
Salbutamol—Headache—Clonidine—hypertension	6.64e-06	8.5e-05	CcSEcCtD
Salbutamol—Dyspepsia—Timolol—hypertension	6.64e-06	8.49e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Losartan—hypertension	6.63e-06	8.48e-05	CcSEcCtD
Salbutamol—Asthenia—Betaxolol—hypertension	6.62e-06	8.47e-05	CcSEcCtD
Salbutamol—Nausea—Valsartan—hypertension	6.61e-06	8.45e-05	CcSEcCtD
Salbutamol—Pruritus—Furosemide—hypertension	6.6e-06	8.44e-05	CcSEcCtD
Salbutamol—Constipation—Ramipril—hypertension	6.6e-06	8.44e-05	CcSEcCtD
Salbutamol—Nausea—Olmesartan—hypertension	6.57e-06	8.41e-05	CcSEcCtD
Salbutamol—Vomiting—Trandolapril—hypertension	6.57e-06	8.41e-05	CcSEcCtD
Salbutamol—Diarrhoea—Perindopril—hypertension	6.56e-06	8.4e-05	CcSEcCtD
Salbutamol—Decreased appetite—Timolol—hypertension	6.55e-06	8.39e-05	CcSEcCtD
Salbutamol—Vomiting—Enalapril—hypertension	6.55e-06	8.38e-05	CcSEcCtD
Salbutamol—Diarrhoea—Irbesartan—hypertension	6.54e-06	8.37e-05	CcSEcCtD
Salbutamol—Hypotension—Lisinopril—hypertension	6.54e-06	8.36e-05	CcSEcCtD
Salbutamol—Dizziness—Captopril—hypertension	6.53e-06	8.36e-05	CcSEcCtD
Salbutamol—Pruritus—Betaxolol—hypertension	6.53e-06	8.36e-05	CcSEcCtD
Salbutamol—Rash—Trandolapril—hypertension	6.52e-06	8.34e-05	CcSEcCtD
Salbutamol—Dermatitis—Trandolapril—hypertension	6.51e-06	8.33e-05	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Timolol—hypertension	6.51e-06	8.33e-05	CcSEcCtD
Salbutamol—Fatigue—Timolol—hypertension	6.5e-06	8.32e-05	CcSEcCtD
Salbutamol—Rash—Enalapril—hypertension	6.49e-06	8.31e-05	CcSEcCtD
Salbutamol—Dermatitis—Enalapril—hypertension	6.49e-06	8.3e-05	CcSEcCtD
Salbutamol—Diarrhoea—Hydrochlorothiazide—hypertension	6.49e-06	8.3e-05	CcSEcCtD
Salbutamol—Headache—Trandolapril—hypertension	6.48e-06	8.29e-05	CcSEcCtD
Salbutamol—Vomiting—Telmisartan—hypertension	6.46e-06	8.26e-05	CcSEcCtD
Salbutamol—Asthenia—Losartan—hypertension	6.45e-06	8.26e-05	CcSEcCtD
Salbutamol—Headache—Enalapril—hypertension	6.45e-06	8.26e-05	CcSEcCtD
Salbutamol—Pain—Timolol—hypertension	6.45e-06	8.25e-05	CcSEcCtD
Salbutamol—Rash—Telmisartan—hypertension	6.4e-06	8.2e-05	CcSEcCtD
Salbutamol—Dermatitis—Telmisartan—hypertension	6.4e-06	8.19e-05	CcSEcCtD
Salbutamol—Diarrhoea—Furosemide—hypertension	6.38e-06	8.16e-05	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Lisinopril—hypertension	6.37e-06	8.15e-05	CcSEcCtD
Salbutamol—Pruritus—Losartan—hypertension	6.36e-06	8.14e-05	CcSEcCtD
Salbutamol—Headache—Telmisartan—hypertension	6.36e-06	8.14e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Ramipril—hypertension	6.36e-06	8.13e-05	CcSEcCtD
Salbutamol—Dizziness—Perindopril—hypertension	6.34e-06	8.11e-05	CcSEcCtD
Salbutamol—Insomnia—Lisinopril—hypertension	6.33e-06	8.1e-05	CcSEcCtD
Salbutamol—Dizziness—Irbesartan—hypertension	6.32e-06	8.09e-05	CcSEcCtD
Salbutamol—Diarrhoea—Betaxolol—hypertension	6.32e-06	8.08e-05	CcSEcCtD
Salbutamol—Gastrointestinal pain—Ramipril—hypertension	6.31e-06	8.07e-05	CcSEcCtD
Salbutamol—Nausea—Clonidine—hypertension	6.3e-06	8.06e-05	CcSEcCtD
Salbutamol—Paraesthesia—Lisinopril—hypertension	6.28e-06	8.04e-05	CcSEcCtD
Salbutamol—Vomiting—Captopril—hypertension	6.28e-06	8.04e-05	CcSEcCtD
Salbutamol—Dizziness—Hydrochlorothiazide—hypertension	6.27e-06	8.02e-05	CcSEcCtD
Salbutamol—Dyspnoea—Lisinopril—hypertension	6.24e-06	7.98e-05	CcSEcCtD
Salbutamol—Rash—Captopril—hypertension	6.23e-06	7.97e-05	CcSEcCtD
Salbutamol—Dermatitis—Captopril—hypertension	6.22e-06	7.96e-05	CcSEcCtD
Salbutamol—Somnolence—Lisinopril—hypertension	6.22e-06	7.96e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Timolol—hypertension	6.21e-06	7.95e-05	CcSEcCtD
Salbutamol—Headache—Captopril—hypertension	6.19e-06	7.92e-05	CcSEcCtD
Salbutamol—Gastrointestinal pain—Timolol—hypertension	6.17e-06	7.89e-05	CcSEcCtD
Salbutamol—Dizziness—Furosemide—hypertension	6.16e-06	7.89e-05	CcSEcCtD
Salbutamol—Dyspepsia—Lisinopril—hypertension	6.16e-06	7.88e-05	CcSEcCtD
Salbutamol—Diarrhoea—Losartan—hypertension	6.15e-06	7.88e-05	CcSEcCtD
Salbutamol—Nausea—Trandolapril—hypertension	6.14e-06	7.86e-05	CcSEcCtD
Salbutamol—Urticaria—Ramipril—hypertension	6.13e-06	7.84e-05	CcSEcCtD
Salbutamol—Nausea—Enalapril—hypertension	6.12e-06	7.83e-05	CcSEcCtD
Salbutamol—Dizziness—Betaxolol—hypertension	6.1e-06	7.81e-05	CcSEcCtD
Salbutamol—Vomiting—Perindopril—hypertension	6.1e-06	7.8e-05	CcSEcCtD
Salbutamol—Body temperature increased—Ramipril—hypertension	6.1e-06	7.8e-05	CcSEcCtD
Salbutamol—Abdominal pain—Ramipril—hypertension	6.1e-06	7.8e-05	CcSEcCtD
Salbutamol—Decreased appetite—Lisinopril—hypertension	6.08e-06	7.78e-05	CcSEcCtD
Salbutamol—Vomiting—Irbesartan—hypertension	6.08e-06	7.78e-05	CcSEcCtD
Salbutamol—Rash—Perindopril—hypertension	6.05e-06	7.74e-05	CcSEcCtD
Salbutamol—Dermatitis—Perindopril—hypertension	6.04e-06	7.73e-05	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Lisinopril—hypertension	6.04e-06	7.73e-05	CcSEcCtD
Salbutamol—Nausea—Telmisartan—hypertension	6.03e-06	7.72e-05	CcSEcCtD
Salbutamol—Fatigue—Lisinopril—hypertension	6.03e-06	7.72e-05	CcSEcCtD
Salbutamol—Vomiting—Hydrochlorothiazide—hypertension	6.03e-06	7.71e-05	CcSEcCtD
Salbutamol—Rash—Irbesartan—hypertension	6.03e-06	7.71e-05	CcSEcCtD
Salbutamol—Dermatitis—Irbesartan—hypertension	6.02e-06	7.7e-05	CcSEcCtD
Salbutamol—Headache—Perindopril—hypertension	6.01e-06	7.69e-05	CcSEcCtD
Salbutamol—Urticaria—Timolol—hypertension	5.99e-06	7.67e-05	CcSEcCtD
Salbutamol—Headache—Irbesartan—hypertension	5.99e-06	7.66e-05	CcSEcCtD
Salbutamol—Constipation—Lisinopril—hypertension	5.98e-06	7.65e-05	CcSEcCtD
Salbutamol—Pain—Lisinopril—hypertension	5.98e-06	7.65e-05	CcSEcCtD
Salbutamol—Rash—Hydrochlorothiazide—hypertension	5.98e-06	7.65e-05	CcSEcCtD
Salbutamol—Dermatitis—Hydrochlorothiazide—hypertension	5.97e-06	7.64e-05	CcSEcCtD
Salbutamol—Body temperature increased—Timolol—hypertension	5.96e-06	7.63e-05	CcSEcCtD
Salbutamol—Abdominal pain—Timolol—hypertension	5.96e-06	7.63e-05	CcSEcCtD
Salbutamol—Dizziness—Losartan—hypertension	5.95e-06	7.61e-05	CcSEcCtD
Salbutamol—Headache—Hydrochlorothiazide—hypertension	5.94e-06	7.6e-05	CcSEcCtD
Salbutamol—Vomiting—Furosemide—hypertension	5.93e-06	7.59e-05	CcSEcCtD
Salbutamol—Rash—Furosemide—hypertension	5.88e-06	7.52e-05	CcSEcCtD
Salbutamol—Dermatitis—Furosemide—hypertension	5.87e-06	7.51e-05	CcSEcCtD
Salbutamol—Vomiting—Betaxolol—hypertension	5.87e-06	7.51e-05	CcSEcCtD
Salbutamol—Nausea—Captopril—hypertension	5.87e-06	7.51e-05	CcSEcCtD
Salbutamol—Headache—Furosemide—hypertension	5.84e-06	7.47e-05	CcSEcCtD
Salbutamol—Rash—Betaxolol—hypertension	5.82e-06	7.45e-05	CcSEcCtD
Salbutamol—Dermatitis—Betaxolol—hypertension	5.81e-06	7.44e-05	CcSEcCtD
Salbutamol—Headache—Betaxolol—hypertension	5.78e-06	7.4e-05	CcSEcCtD
Salbutamol—Feeling abnormal—Lisinopril—hypertension	5.76e-06	7.38e-05	CcSEcCtD
Salbutamol—Gastrointestinal pain—Lisinopril—hypertension	5.72e-06	7.32e-05	CcSEcCtD
Salbutamol—Vomiting—Losartan—hypertension	5.72e-06	7.32e-05	CcSEcCtD
Salbutamol—Nausea—Perindopril—hypertension	5.7e-06	7.29e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Ramipril—hypertension	5.68e-06	7.27e-05	CcSEcCtD
Salbutamol—Nausea—Irbesartan—hypertension	5.68e-06	7.26e-05	CcSEcCtD
Salbutamol—Rash—Losartan—hypertension	5.67e-06	7.26e-05	CcSEcCtD
Salbutamol—Dermatitis—Losartan—hypertension	5.67e-06	7.25e-05	CcSEcCtD
Salbutamol—Headache—Losartan—hypertension	5.64e-06	7.21e-05	CcSEcCtD
Salbutamol—Nausea—Hydrochlorothiazide—hypertension	5.63e-06	7.21e-05	CcSEcCtD
Salbutamol—Urticaria—Lisinopril—hypertension	5.56e-06	7.11e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Timolol—hypertension	5.56e-06	7.11e-05	CcSEcCtD
Salbutamol—Nausea—Furosemide—hypertension	5.54e-06	7.09e-05	CcSEcCtD
Salbutamol—Asthenia—Ramipril—hypertension	5.53e-06	7.08e-05	CcSEcCtD
Salbutamol—Body temperature increased—Lisinopril—hypertension	5.53e-06	7.08e-05	CcSEcCtD
Salbutamol—Abdominal pain—Lisinopril—hypertension	5.53e-06	7.08e-05	CcSEcCtD
Salbutamol—Nausea—Betaxolol—hypertension	5.48e-06	7.02e-05	CcSEcCtD
Salbutamol—Pruritus—Ramipril—hypertension	5.46e-06	6.98e-05	CcSEcCtD
Salbutamol—Asthenia—Timolol—hypertension	5.41e-06	6.92e-05	CcSEcCtD
Salbutamol—Nausea—Losartan—hypertension	5.34e-06	6.84e-05	CcSEcCtD
Salbutamol—Pruritus—Timolol—hypertension	5.33e-06	6.83e-05	CcSEcCtD
Salbutamol—Diarrhoea—Ramipril—hypertension	5.28e-06	6.75e-05	CcSEcCtD
Salbutamol—Diarrhoea—Timolol—hypertension	5.16e-06	6.6e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Lisinopril—hypertension	5.15e-06	6.59e-05	CcSEcCtD
Salbutamol—Dizziness—Ramipril—hypertension	5.1e-06	6.53e-05	CcSEcCtD
Salbutamol—Asthenia—Lisinopril—hypertension	5.02e-06	6.42e-05	CcSEcCtD
Salbutamol—Dizziness—Timolol—hypertension	4.99e-06	6.38e-05	CcSEcCtD
Salbutamol—Pruritus—Lisinopril—hypertension	4.95e-06	6.33e-05	CcSEcCtD
Salbutamol—Vomiting—Ramipril—hypertension	4.9e-06	6.28e-05	CcSEcCtD
Salbutamol—Rash—Ramipril—hypertension	4.86e-06	6.22e-05	CcSEcCtD
Salbutamol—Dermatitis—Ramipril—hypertension	4.86e-06	6.22e-05	CcSEcCtD
Salbutamol—Headache—Ramipril—hypertension	4.83e-06	6.18e-05	CcSEcCtD
Salbutamol—Vomiting—Timolol—hypertension	4.79e-06	6.13e-05	CcSEcCtD
Salbutamol—Diarrhoea—Lisinopril—hypertension	4.79e-06	6.12e-05	CcSEcCtD
Salbutamol—Rash—Timolol—hypertension	4.75e-06	6.08e-05	CcSEcCtD
Salbutamol—Dermatitis—Timolol—hypertension	4.75e-06	6.08e-05	CcSEcCtD
Salbutamol—Headache—Timolol—hypertension	4.72e-06	6.04e-05	CcSEcCtD
Salbutamol—Dizziness—Lisinopril—hypertension	4.63e-06	5.92e-05	CcSEcCtD
Salbutamol—Nausea—Ramipril—hypertension	4.58e-06	5.86e-05	CcSEcCtD
Salbutamol—Nausea—Timolol—hypertension	4.48e-06	5.73e-05	CcSEcCtD
Salbutamol—Vomiting—Lisinopril—hypertension	4.45e-06	5.69e-05	CcSEcCtD
Salbutamol—Rash—Lisinopril—hypertension	4.41e-06	5.64e-05	CcSEcCtD
Salbutamol—Dermatitis—Lisinopril—hypertension	4.41e-06	5.64e-05	CcSEcCtD
Salbutamol—Headache—Lisinopril—hypertension	4.38e-06	5.61e-05	CcSEcCtD
Salbutamol—Nausea—Lisinopril—hypertension	4.15e-06	5.32e-05	CcSEcCtD
Salbutamol—ADRB1—Signaling by GPCR—AKT2—hypertension	2.71e-06	9.77e-05	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3R1—hypertension	2.71e-06	9.76e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—hypertension	2.7e-06	9.73e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL10—hypertension	2.69e-06	9.69e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLG—hypertension	2.68e-06	9.66e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—RHOA—hypertension	2.68e-06	9.65e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADRB2—hypertension	2.67e-06	9.62e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ARG1—hypertension	2.67e-06	9.61e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DECR1—hypertension	2.67e-06	9.61e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GLS2—hypertension	2.67e-06	9.61e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COX5B—hypertension	2.67e-06	9.61e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT2—hypertension	2.65e-06	9.56e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3R1—hypertension	2.65e-06	9.55e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCE—hypertension	2.63e-06	9.5e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VAV3—hypertension	2.6e-06	9.38e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDGFA—hypertension	2.6e-06	9.38e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCE—hypertension	2.58e-06	9.29e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFBR2—hypertension	2.57e-06	9.25e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VAV3—hypertension	2.55e-06	9.17e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDGFA—hypertension	2.55e-06	9.17e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GNB3—hypertension	2.54e-06	9.16e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALAD—hypertension	2.53e-06	9.11e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFBR2—hypertension	2.51e-06	9.04e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AVP—hypertension	2.51e-06	9.04e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GNB3—hypertension	2.49e-06	8.96e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—RHOA—hypertension	2.49e-06	8.96e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GNAS—hypertension	2.47e-06	8.92e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3R1—hypertension	2.46e-06	8.86e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AVP—hypertension	2.45e-06	8.84e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—RHOA—hypertension	2.43e-06	8.76e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOB—hypertension	2.42e-06	8.73e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GNAS—hypertension	2.42e-06	8.72e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTK2—hypertension	2.41e-06	8.7e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLCE1—hypertension	2.41e-06	8.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—STS—hypertension	2.41e-06	8.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH7A1—hypertension	2.41e-06	8.69e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3R1—hypertension	2.41e-06	8.67e-05	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CXCL8—hypertension	2.4e-06	8.66e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EDN1—hypertension	2.38e-06	8.59e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOB—hypertension	2.37e-06	8.54e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL5—hypertension	2.37e-06	8.53e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTK2—hypertension	2.36e-06	8.51e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CXCL8—hypertension	2.35e-06	8.47e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EDN1—hypertension	2.33e-06	8.41e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL5—hypertension	2.31e-06	8.34e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LPL—hypertension	2.31e-06	8.34e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CBS—hypertension	2.31e-06	8.34e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ARG2—hypertension	2.31e-06	8.34e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP4A11—hypertension	2.31e-06	8.34e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—H2AFX—hypertension	2.3e-06	8.28e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RPS6KB1—hypertension	2.29e-06	8.26e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDGFRB—hypertension	2.29e-06	8.26e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—XDH—hypertension	2.27e-06	8.17e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADCY5—hypertension	2.27e-06	8.16e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LPL—hypertension	2.26e-06	8.16e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCG—hypertension	2.25e-06	8.11e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—H2AFX—hypertension	2.25e-06	8.1e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RPS6KB1—hypertension	2.24e-06	8.08e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDGFRB—hypertension	2.24e-06	8.08e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ITGB3—hypertension	2.23e-06	8.05e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCA—hypertension	2.23e-06	8.05e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGIS—hypertension	2.23e-06	8.02e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC5A2—hypertension	2.23e-06	8.02e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP3A5—hypertension	2.23e-06	8.02e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—YWHAZ—hypertension	2.22e-06	7.99e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADCY5—hypertension	2.22e-06	7.99e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCG—hypertension	2.2e-06	7.93e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NGF—hypertension	2.19e-06	7.9e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SPP1—hypertension	2.19e-06	7.9e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ITGB3—hypertension	2.19e-06	7.88e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCA—hypertension	2.19e-06	7.88e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CXCL8—hypertension	2.18e-06	7.86e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—YWHAZ—hypertension	2.17e-06	7.81e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TPH1—hypertension	2.15e-06	7.75e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCC1—hypertension	2.15e-06	7.75e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSD11B1—hypertension	2.15e-06	7.75e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UCP3—hypertension	2.15e-06	7.75e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UCP2—hypertension	2.15e-06	7.75e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NGF—hypertension	2.14e-06	7.73e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SPP1—hypertension	2.14e-06	7.73e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CXCL8—hypertension	2.13e-06	7.69e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCR5—hypertension	2.13e-06	7.68e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCD—hypertension	2.13e-06	7.68e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—hypertension	2.09e-06	7.52e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCD—hypertension	2.09e-06	7.52e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCR5—hypertension	2.09e-06	7.52e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—C3—hypertension	2.08e-06	7.51e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALAS1—hypertension	2.08e-06	7.5e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP11B2—hypertension	2.08e-06	7.5e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC2A3—hypertension	2.08e-06	7.5e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSD3B1—hypertension	2.05e-06	7.39e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADA—hypertension	2.05e-06	7.39e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—hypertension	2.04e-06	7.36e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—C3—hypertension	2.04e-06	7.34e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDGFB—hypertension	2.03e-06	7.31e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AQP1—hypertension	2.02e-06	7.29e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FADS1—hypertension	2.02e-06	7.29e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGFR1—hypertension	2.02e-06	7.27e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.99e-06	7.16e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.98e-06	7.15e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AGT—hypertension	1.98e-06	7.13e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.97e-06	7.11e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CA9—hypertension	1.97e-06	7.09e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TBXAS1—hypertension	1.97e-06	7.09e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CALM1—hypertension	1.95e-06	7.01e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.94e-06	7e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—hypertension	1.94e-06	6.99e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOE—hypertension	1.94e-06	6.99e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AGT—hypertension	1.94e-06	6.98e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CAV1—hypertension	1.92e-06	6.93e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOA1—hypertension	1.92e-06	6.91e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX15—hypertension	1.92e-06	6.91e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX5AP—hypertension	1.92e-06	6.91e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CALM1—hypertension	1.9e-06	6.86e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KDR—hypertension	1.9e-06	6.85e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOE—hypertension	1.9e-06	6.84e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—hypertension	1.9e-06	6.84e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CAV1—hypertension	1.88e-06	6.77e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOA1—hypertension	1.88e-06	6.76e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HADHA—hypertension	1.87e-06	6.74e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LHB—hypertension	1.87e-06	6.74e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KDR—hypertension	1.86e-06	6.7e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—F2—hypertension	1.83e-06	6.59e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FN1—hypertension	1.83e-06	6.59e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.83e-06	6.59e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPA—hypertension	1.83e-06	6.59e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—KCNJ11—hypertension	1.83e-06	6.59e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSD3B2—hypertension	1.83e-06	6.59e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.79e-06	6.45e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—F2—hypertension	1.79e-06	6.45e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.79e-06	6.45e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FN1—hypertension	1.79e-06	6.45e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LRP2—hypertension	1.75e-06	6.32e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2C18—hypertension	1.75e-06	6.32e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.75e-06	6.31e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSPG2—hypertension	1.69e-06	6.08e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—hypertension	1.67e-06	6e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—INS—hypertension	1.66e-06	5.97e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—hypertension	1.63e-06	5.88e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—hypertension	1.63e-06	5.87e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALOX5—hypertension	1.63e-06	5.87e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GLP1R—hypertension	1.63e-06	5.87e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—INS—hypertension	1.62e-06	5.84e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—hypertension	1.6e-06	5.78e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT2—hypertension	1.6e-06	5.77e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—EGFR—hypertension	1.59e-06	5.75e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—hypertension	1.59e-06	5.75e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—hypertension	1.57e-06	5.65e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT2—hypertension	1.57e-06	5.65e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—EGFR—hypertension	1.56e-06	5.62e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—hypertension	1.52e-06	5.49e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH2—hypertension	1.49e-06	5.37e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—hypertension	1.49e-06	5.37e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGF2—hypertension	1.47e-06	5.31e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RHOA—hypertension	1.47e-06	5.29e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—hypertension	1.45e-06	5.24e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3R1—hypertension	1.45e-06	5.24e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HBA1—hypertension	1.45e-06	5.23e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP11A1—hypertension	1.44e-06	5.2e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGF2—hypertension	1.44e-06	5.19e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RHOA—hypertension	1.44e-06	5.18e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3R1—hypertension	1.42e-06	5.12e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—hypertension	1.42e-06	5.12e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC9A1—hypertension	1.42e-06	5.11e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTT1—hypertension	1.42e-06	5.11e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCLC—hypertension	1.4e-06	5.05e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CETP—hypertension	1.4e-06	5.05e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RELA—hypertension	1.37e-06	4.93e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP17A1—hypertension	1.34e-06	4.84e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MTOR—hypertension	1.34e-06	4.83e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RELA—hypertension	1.34e-06	4.82e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ENO1—hypertension	1.33e-06	4.79e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS1—hypertension	1.33e-06	4.79e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MTOR—hypertension	1.31e-06	4.73e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL8—hypertension	1.29e-06	4.65e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CTGF—hypertension	1.28e-06	4.61e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT2—hypertension	1.27e-06	4.57e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMGCR—hypertension	1.27e-06	4.57e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL8—hypertension	1.26e-06	4.54e-05	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT1—hypertension	1.25e-06	4.49e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADRA2A—hypertension	1.24e-06	4.47e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—hypertension	1.23e-06	4.42e-05	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT1—hypertension	1.22e-06	4.39e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—hypertension	1.2e-06	4.32e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP9—hypertension	1.17e-06	4.2e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CDKN1A—hypertension	1.16e-06	4.19e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TH—hypertension	1.16e-06	4.18e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTEN—hypertension	1.16e-06	4.18e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CALM2—hypertension	1.16e-06	4.17e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP9—hypertension	1.14e-06	4.11e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CDKN1A—hypertension	1.14e-06	4.1e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK8—hypertension	1.13e-06	4.09e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTEN—hypertension	1.13e-06	4.09e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT1—hypertension	1.13e-06	4.07e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCG—hypertension	1.13e-06	4.07e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC2A4—hypertension	1.13e-06	4.07e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK8—hypertension	1.11e-06	4e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT1—hypertension	1.11e-06	3.99e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EP300—hypertension	1.11e-06	3.98e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT1—hypertension	1.09e-06	3.94e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EP300—hypertension	1.08e-06	3.9e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SRC—hypertension	1.07e-06	3.87e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP19A1—hypertension	1.06e-06	3.83e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—STK11—hypertension	1.06e-06	3.83e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SRC—hypertension	1.05e-06	3.79e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VEGFA—hypertension	1.05e-06	3.77e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VEGFA—hypertension	1.02e-06	3.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COMT—hypertension	9.87e-07	3.56e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARGC1A—hypertension	9.73e-07	3.51e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GNB3—hypertension	9.73e-07	3.51e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMOX1—hypertension	9.69e-07	3.49e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MYC—hypertension	9.63e-07	3.47e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—hypertension	9.61e-07	3.46e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAT—hypertension	9.56e-07	3.45e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GNAS—hypertension	9.48e-07	3.42e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MYC—hypertension	9.42e-07	3.4e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EGFR—hypertension	9.42e-07	3.4e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—hypertension	9.4e-07	3.39e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOB—hypertension	9.28e-07	3.35e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EGFR—hypertension	9.21e-07	3.32e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM1—hypertension	9.03e-07	3.25e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPL—hypertension	8.86e-07	3.19e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADCY5—hypertension	8.68e-07	3.13e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX1—hypertension	8.65e-07	3.12e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRKCA—hypertension	8.56e-07	3.08e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP1A1—hypertension	8.56e-07	3.08e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CD36—hypertension	8.42e-07	3.03e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—hypertension	7.98e-07	2.88e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TP53—hypertension	7.91e-07	2.85e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARA—hypertension	7.83e-07	2.82e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TP53—hypertension	7.74e-07	2.79e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AGT—hypertension	7.58e-07	2.73e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CALM1—hypertension	7.45e-07	2.69e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOE—hypertension	7.43e-07	2.68e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAV1—hypertension	7.36e-07	2.65e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA1—hypertension	7.34e-07	2.65e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—hypertension	7.24e-07	2.61e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—hypertension	7.08e-07	2.55e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT1—hypertension	6.68e-07	2.41e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT1—hypertension	6.53e-07	2.35e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARG—hypertension	6.47e-07	2.33e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—hypertension	6.38e-07	2.3e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INS—hypertension	6.35e-07	2.29e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—hypertension	5.82e-07	2.1e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—hypertension	5.57e-07	2.01e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3R1—hypertension	5.57e-07	2.01e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—hypertension	5.09e-07	1.83e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTEN—hypertension	4.44e-07	1.6e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—EP300—hypertension	4.23e-07	1.53e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKT1—hypertension	2.56e-07	9.22e-06	CbGpPWpGaD
